From 01 April 2020 to 31 March 2021, the MHRA’s Good Pharmacovigilance Practice Inspectorate (GPvP) conducted 37 pharmacovigilance (PV) inspections on 36 marketing authorisation holders (MAHs) to evaluate its PV processes and compliance with existing EU and national PV regulations.
Read MoreA look at four areas where contingency plans are urgently needed to Brexit-proof your PV system.
Read MoreA look at four areas where increased cross-functional collaboration and understanding can yield benefits, both immediately and also downstream.
Read MoreVery grateful to PIPA allowing me to publish the full article here, so non-members can see it.
Read MoreThe EMA recently released it's two-year report on the PRIority MEdicines (PRIME) scheme...
Read MoreSee the latest edition of PIPELINE for my thoughts on the utilisation of social media data in pharmacovigilance…
Read More